A panel of human metastatic melanoma cell lines were treated with varying concentrations of the KPT-185 XPO1 inhibitor (Range  = 0–10.24 μM) or DMSO (vehicle) as a negative control. The gene discussed is XPO1; the disease is metastatic melanoma.